| 10/25/2024 | IG | Market Commentary: High-grade primary pace slows, pipeline thins ahead of Election; corporate flows drop
|
| 10/22/2024 | IG | New Issue: Elevance Health sells $5.2 billion of senior notes in six tranches
|
| 10/22/2024 | IG | Fitch gives Elevance Health notes BBB+
|
| 10/22/2024 | IG | Moody’s rates Elevance Health notes Baa2
|
| 10/22/2024 | IG | S&P rates Elevance Health notes A
|
| 5/20/2024 | IG | New Issue: Elevance Health sells $2.6 billion of senior notes in three tranches
|
| 5/20/2024 | IG | Fitch rates Elevance notes BBB+
|
| 5/20/2024 | IG | Elevance to offer notes due 2029, 2034, 2054 via three bookrunners
|
| 5/20/2024 | IG | S&P gives A to Elevance notes
|
| 5/20/2024 | IG | Moody's assigns Elevance notes Baa2
|
| 3/6/2024 | IG | S&P revises Elevance outlook to negative
|
| 2/6/2024 | IG | Moody’s turns Elevance view to positive
|
| 1/26/2024 | IG | Fitch raises Elevance Health
|
| 2/3/2023 | IG | Market Commentary: Investment-grade primary slows; bonds print tight; uptick in deals eyed in week ahead
|
| 1/31/2023 | IG | Moody’s rates Elevance notes Baa2
|
| 1/30/2023 | IG | New Issue: Elevance Health sells $2.6 billion of senior notes in three tranches
|
| 1/30/2023 | IG | Fitch rates Elevance notes BBB
|
| 1/30/2023 | IG | S&P rates Elevance notes A
|
| 1/30/2023 | IG | Elevance Health to price fixed-rate notes due 2026, 2033, 2053
|
| 10/26/2022 | IG | New Issue: Elevance Health sells $1.8 billion of senior notes in three tranches
|
| 10/26/2022 | IG | S&P gives Elevance notes A
|
| 10/26/2022 | IG | Fitch rates Elevance notes BBB
|
| 10/26/2022 | IG | Moody’s assigns Elevance notes Baa2
|
| 10/26/2022 | IG | Elevance Health to price fixed-rate notes due 2025, 2032, 2052
|
